Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services
FDA, U.S. Food and Drug Administration
U.S. Food & Drug Administration
 
  • A to Z Index
  • Follow FDA
  • FDA Voice Blog
Search
 
Most Popular Searches
 
  • Home
  • Food
  • Drugs
  • Medical Devices
  • Vaccines, Blood & Biologics
  • Animal & Veterinary
  • Cosmetics
  • Radiation-Emitting Products
  • Tobacco Products
 

Import Alert for Industry Bio & Licensed In-Vivo & In-Vitro Diag

  • Print
  • Share
  • E-mail
  • FDA Home
  • Import Program
  • Import Alerts
  • Industry Categories
  • Industry Group
-

Bio & Licensed In-Vivo & In-Vitro Diag


DWPE = Detain without physical examination
Import Alert Number Import Alert Type Publish Date Import Alert Name
57-06 DWPE 03/18/2011 "Detention Without Physical Examination of 714x Cancer/Aids Serum"
57-10 DWPE 03/18/2011 "Detention Without Physicla Examination of HTLV Blot 2.4 And HIV 1 Blot 1.3 From Genelabs Diagnostics Pte, Ltd, Singapore"
57-11 DWPE 03/18/2011 "Unlicensed Immune Globulin Intravenous (Human) From the United Kingdom"
57-14 DWPE 03/18/2011 "Biologic Drugs From Firms That Have Not Met Drug GMPs"
57-15 DWPE 03/18/2011 "Detention Without Physical Examination of Allergens And/Or Allergenic Products"
57-16 DWPE with Surveillance 03/18/2011 "Purified Urokinase Powder From China Or Other Foreign Sources"
57-17 DWPE with Surveillance 10/25/2012 "Detention Without Physical Examination of Unlicensed Botulinum Toxin"
57-18 DWPE with Surveillance 03/18/2011 "Unlicensed Biologic Known As "THE ANTIDOTE""
57-20 DWPE 03/18/2011 "Imported Dura Mater Regulated Under Section 361 Of The Public Health Service Act (PHS Act)"
57-21 DWPE 12/05/2011 *** Detention without Physical Examination Of Whipworms and Hookworms Including Eggs and Larvae***
62-07 DWPE 12/14/2012 "Detention Without Physical Examination of Shipments of Sygen Injectable (Bovine-Extracted GMI Monosialoganglioside)"
66-14 DWPE with Surveillance 03/18/2011 "Reimportation of All Prescription Drugs for Human Use"
66-40 DWPE 05/22/2013 "Detention Without Physical Examination of Drugs From Firms Which Have Not Met Drug GMPs"
89-08 DWPE 05/05/2013 "Detention Without Physical Examination of Class III Devices Without Approved PMA's Or IDE's and Other Devices Not Equivalent or No 510k"
-
-

Links on this page:

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.


  • Accessibility
  • Contact FDA
  • Careers
  • FDA Basics
  • FOIA
  • No Fear Act
  • Site Map
  • Transparency
  • Website Policies
FDA
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
Ph. 1-888-INFO-FDA (1-888-463-6332)
Email FDA
  • USA.gov
  • E-mail
  • RSS
  • Twitter
  • Facebook
  • YouTube
  • Flickr
  • For Government
  • For Press
  • Combination Products
  • Advisory Committees
  • Science & Research
  • Regulatory Information
  • Safety
  • Emergency Preparedness
  • International Programs
  • News & Events
  • Training and Continuing Education
  • Inspections/Compliance
  • State & Local Officials
  • Consumers
  • Industry
  • Health Professionals
U.S. Department of Health & Human Services
 

Links on this page: